Ocular Therapeutix, Inc. (OCUL) Financials

OCUL Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 252.1 million 160.9 million
2023-09-30 162.4 million 154.5 million
2023-06-30 122.6 million 119.5 million
2023-03-31 128.6 million 118.9 million

OCUL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -17.7 million 4.3 million
2023-09-30 -8.0 million 4.5 million
2023-06-30 -22.1 million 4.4 million
2023-03-31 -23.4 million 4.6 million

OCUL Net Income

No data available :(

OCUL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 196.0 million - 8.5 million
2023-09-30 110.6 million - 9.1 million
2023-06-30 66.6 million 53.3 million 9.4 million
2023-03-31 79.0 million 54.7 million 9.9 million

OCUL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 84.4 million
2023-09-30 85.1 million
2023-06-30 78.0 million
2023-03-31 77.4 million

OCUL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 459000 16.2 million 43.7 million 26.5 million
2023-09-30 259000 15.0 million 8.6 million 9.3 million
2023-06-30 2.0 million 15.1 million 8.2 million 11.2 million
2023-03-31 3.4 million 14.7 million 9.1 million 10.8 million

OCUL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 14.8 million 1.4 million
2023-09-30 15.0 million 1.4 million
2023-06-30 15.2 million 1.3 million
2023-03-31 13.4 million 1.2 million

OCUL

Price: $6.17

52 week price:
2.00
11.31

Payout Ratio Range:
-22.93%
-16.36%

Earnings Per Share: -1.01 USD

P/E Ratio: -5.56

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 567800

Ebitda: -14.6 million

Market Capitalization: 1.4 billion

Links: